As of May 29
| -0.03 / -1.38%|
The 7 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 6.50, with a high estimate of 15.00 and a low estimate of 1.00. The median estimate represents a +203.74% increase from the last price of 2.14.
The current consensus among 8 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.